It is marketed for weight management as Saxenda and for type 2 diabetes as Victoza
When the sweating stops, you may feel cold
(6) Sustained-release formulations
One in 8 American adults reports using a glucagon-like peptide 1 receptor agonist (GLP-1RA) medication, and prescriptions continue to increase due to these drugs effectiveness in reducing cardiovascular mortality and treating diabetes and obesity
By comparison, the injectable version of Wegovy can cost more than $1,300 for a 28-day supply without savings programs or insurance
They set up a policy where compounders could work around FDA approval guidelines in cases of shortages. But right now, there is no shortage of GLP-1 medications, and because companies like Eli Lilly and Novo Nordisk have patents, patients are likely years away from FDA-approved generics